Noesis Capital Mangement Corp Makes New $356,000 Investment in Procter & Gamble Company (The) (NYSE:PG)

Noesis Capital Mangement Corp bought a new position in Procter & Gamble Company (The) (NYSE:PG) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,088 shares of the company’s stock, valued at approximately $356,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Guardian Wealth Management Inc. raised its position in shares of Procter & Gamble by 4.4% during the first quarter. Guardian Wealth Management Inc. now owns 15,958 shares of the company’s stock worth $2,720,000 after purchasing an additional 676 shares during the period. Dempze Nancy E raised its position in shares of Procter & Gamble by 5.0% during the first quarter. Dempze Nancy E now owns 25,083 shares of the company’s stock worth $4,275,000 after purchasing an additional 1,195 shares during the period. AE Wealth Management LLC raised its position in shares of Procter & Gamble by 8.2% during the first quarter. AE Wealth Management LLC now owns 553,040 shares of the company’s stock worth $94,249,000 after purchasing an additional 41,985 shares during the period. Hendershot Investments Inc. raised its position in shares of Procter & Gamble by 0.8% during the first quarter. Hendershot Investments Inc. now owns 16,925 shares of the company’s stock worth $2,884,000 after purchasing an additional 137 shares during the period. Finally, Abel Hall LLC raised its position in shares of Procter & Gamble by 50.9% during the first quarter. Abel Hall LLC now owns 2,732 shares of the company’s stock worth $466,000 after purchasing an additional 922 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent research reports. Raymond James Financial lowered their target price on Procter & Gamble from $190.00 to $185.00 and set an “outperform” rating on the stock in a research note on Friday, April 25th. Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the stock an “overweight” rating in a research report on Friday, April 25th. UBS Group lowered their target price on shares of Procter & Gamble from $186.00 to $180.00 and set a “buy” rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $181.00 to $172.00 and set an “overweight” rating on the stock in a research report on Friday, April 11th. Finally, Citigroup decreased their target price on Procter & Gamble from $200.00 to $181.00 and set a “buy” rating for the company in a research note on Friday, April 25th. Nine analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $176.17.

Insiders Place Their Bets

In related news, CEO Jennifer L. Davis sold 1,000 shares of the company’s stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the transaction, the chief executive officer owned 51,965 shares of the company’s stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business’s stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the sale, the insider owned 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.

Procter & Gamble Stock Down 0.1%

Shares of NYSE:PG opened at $158.23 on Thursday. The stock’s 50-day moving average price is $161.19 and its 200-day moving average price is $164.26. Procter & Gamble Company has a 12-month low of $151.90 and a 12-month high of $180.43. The stock has a market capitalization of $370.98 billion, a P/E ratio of 25.12, a price-to-earnings-growth ratio of 4.51 and a beta of 0.40. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47.

Procter & Gamble (NYSE:PG) last released its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.01. The firm had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The business’s revenue was down 2.1% on a year-over-year basis. During the same period last year, the business earned $1.52 earnings per share. On average, equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $1.0568 per share. The ex-dividend date is Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.67%. Procter & Gamble’s dividend payout ratio is presently 66.98%.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.